Literature DB >> 25614287

Impaired integrin β3 delays endothelial cell regeneration and contributes to arteriovenous graft failure in mice.

Ming Liang1, Yun Wang1, Anlin Liang1, Jin-Fei Dong1, Jie Du1, Jizhong Cheng2.   

Abstract

OBJECTIVE: Neointima formation is associated with stenosis and subsequent thrombosis in arteriovenous grafts (AVGs). A role of integrin β3 in the neointima formation of AVGs remains poorly understood. APPROACH AND
RESULTS: In integrin β3(-/-) mice, we found significantly accelerated occlusion of AVGs compared with the wild-type mice. This is caused by the development of neointima and lack of endothelial regeneration. The latter is a direct consequence of impaired functions of circulating angiogenic cells (CACs) and platelets in integrin β3(-/-) mice. Evidence suggests the involvement of platelet regulating CAC homing to and differentiation at graft sites via transforming growth factor-β1 and Notch signaling pathway. First, CACs deficient of integrin β3 impaired adhesion activity toward exposed subendothelium. Second, platelets from integrin β3(-/-) mice failed to sufficiently stimulate CACs to differentiate into mature endothelial cells. Finally, we found that transforming growth factor-β1 level was increased in platelets from integrin β3(-/-) mice and resulted in enhanced Notch1 activation in CACs in AVGs. These results demonstrate that integrin β3 is critical for endothelial cell homing and differentiation. The increased transforming growth factor-β1 and Notch1 signaling mediates integrin β3(-/-)-induced AVG occlusion. This accelerated occlusion of AVGs was reversed in integrin β3(-/-) mice transplanted with the bone marrow from wild-type mice.
CONCLUSIONS: Our results suggest that boosting integrin β3 function in the endothelial cells and platelets could prevent neointima and thrombosis in AVGs.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  arteriovenous graft; circulating angiogenic cells; integrin β3; neointima

Mesh:

Substances:

Year:  2015        PMID: 25614287      PMCID: PMC4671198          DOI: 10.1161/ATVBAHA.114.305089

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

1.  Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells.

Authors:  Yanhua Hu; Fergus Davison; Zhongyi Zhang; Qingbo Xu
Journal:  Circulation       Date:  2003-12-01       Impact factor: 29.690

2.  Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts.

Authors:  Christian Heim; Sebastian Eckl; Raimund Preidl; Martina Ramsperger-Gleixner; Nina Koch; Katja Goldmann; Bernd M Spriewald; Michael Weyand; Stephan M Ensminger
Journal:  Eur J Cardiothorac Surg       Date:  2014-03-27       Impact factor: 4.191

3.  Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice.

Authors:  Qingbo Xu; Zhongyi Zhang; Fergus Davison; Yanhua Hu
Journal:  Circ Res       Date:  2003-09-25       Impact factor: 17.367

4.  Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.

Authors:  Jiri Zavadil; Lukas Cermak; Noemi Soto-Nieves; Erwin P Böttinger
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

5.  Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice.

Authors:  Eric T Choi; M Faisal Khan; Jeremy E Leidenfrost; Emily T Collins; Kenneth P Boc; Brian R Villa; Deborah V Novack; William C Parks; Dana R Abendschein
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

6.  Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.

Authors:  Dirk H Walter; Kilian Rittig; Ferdinand H Bahlmann; Rudolf Kirchmair; Marcy Silver; Toshinori Murayama; Hiromi Nishimura; Douglas W Losordo; Takayuki Asahara; Jeffrey M Isner
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

7.  Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury.

Authors:  Nikos Werner; Stefan Junk; Ulrich Laufs; Andreas Link; Katrin Walenta; Michael Bohm; Georg Nickenig
Journal:  Circ Res       Date:  2003-06-26       Impact factor: 17.367

8.  Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally.

Authors:  Andrés Hidalgo; Linnea A Weiss; Paul S Frenette
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.

Authors:  Brian C Cooley; Jose Nevado; Jason Mellad; Dan Yang; Cynthia St Hilaire; Alejandra Negro; Fang Fang; Guibin Chen; Hong San; Avram D Walts; Robin L Schwartzbeck; Brandi Taylor; Jan D Lanzer; Andrew Wragg; Abdalla Elagha; Leilani E Beltran; Colin Berry; Robert Feil; Renu Virmani; Elena Ladich; Jason C Kovacic; Manfred Boehm
Journal:  Sci Transl Med       Date:  2014-03-12       Impact factor: 17.956

10.  Insulin-like growth factor binding protein-3 is present in the alpha-granules of platelets.

Authors:  E M Spencer; A Tokunaga; T K Hunt
Journal:  Endocrinology       Date:  1993-03       Impact factor: 4.736

View more
  6 in total

1.  Notch signaling in bone marrow-derived FSP-1 cells initiates neointima formation in arteriovenous fistulas.

Authors:  Ming Liang; Qunying Guo; Fengzhang Huang; Guofeng Han; Ke Song; Jinlong Luo; Hunter Cheng; Hongzhen Hu; Eric K Peden; Changyi Chen; William E Mitch; Jie Du; Xiaodong Fu; Luan Truong; Jizhong Cheng
Journal:  Kidney Int       Date:  2019-02-21       Impact factor: 10.612

Review 2.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

Review 3.  Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?

Authors:  Ding-Yuan Tian; Xu-Rui Jin; Xi Zeng; Yun Wang
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

4.  Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells.

Authors:  Emma Ristori; Vittoria Cicaloni; Laura Salvini; Laura Tinti; Cristina Tinti; Michael Simons; Federico Corti; Sandra Donnini; Marina Ziche
Journal:  Cells       Date:  2020-11-19       Impact factor: 6.600

Review 5.  Inflammation in Vein Graft Disease.

Authors:  Margreet R de Vries; Paul H A Quax
Journal:  Front Cardiovasc Med       Date:  2018-01-24

6.  PDGFRA in vascular adventitial MSCs promotes neointima formation in arteriovenous fistula in chronic kidney disease.

Authors:  Ke Song; Ying Qing; Qunying Guo; Eric K Peden; Changyi Chen; William E Mitch; Luan Truong; Jizhong Cheng
Journal:  JCI Insight       Date:  2020-11-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.